Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Stéphanie Forté, MD MSc, FRCPC, Nafanta Fadiga, Olivia Pestrin, John Chinawaeze Aneke, MBBS, FMCPath, Shivani Bhat, MPH, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2018-99-119716

Published: 2018

Journal Articles

Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease Patients

Rebecca Marie Rosart, MD, Olivia A. Pestrin, George A. Tomlinson, PhD BSc, MSc, Richard Ward, MBBS, MRCP, Jacob Pendergrast, MD FRCPC, Andrew Binding, MD MSc, FRCPC, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 2287.

https://doi.org/10.1182/blood-2018-99-111364

Published: 2018

Journal Articles

Real World Experience with Sublingual Fentanyl for the Treatment of Sickle Cell Vaso-Occlusive Episodes in Adults in a Tertiary Canadian Emergency Department

Hayley Merkeley, MD, Sam Sabbah, MBBS, MSc, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc,FRCPC

Blood (2018) 132 (Supplement 1): 5879.

https://doi.org/10.1182/blood-2018-99-116676

Published: 2018

Journal Articles

Should Women with Sickle Cell Disease be Administered Prophylactic Transfusions to Avoid Complications during Pregnancy?

Patricia Palcu, BSc, Kevin H. M. Kuo, MDMSc, FRCPC, Richard Ward, MBBS, MRCP, Nusrat Zaffar, MD, Ann Kinga Malinowski, MD MSc, FRCSC, Nadine Shehata, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 3679.

https://doi.org/10.1182/blood-2018-99-112133

Published: 2018

Journal Articles

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Brett L. Houston, MD, Christine M. Cserti-Gazdewich, MD, Richard Ward, MBBS, Jean St. Louis, MD, Georges E. Rivard, MD, Jerome M. Teitel, MD, Michelle Sholzberg, MD

Blood (2015) 126 (23): 4701.

https://doi.org/10.1182/blood.V126.23.4701.4701

Published: 2015

Journal Articles

Hemoglobinopathy Education in Canadian Hematology Training Programs: How Much Are Residents Learning?

Madeleine M Verhovsek, BSc, MD FRCPC, Vicky R Breakey, BSc, MD MD FRCPC, Richard Ward, MBBS, MSc, MRCP, FRCPath, Shannon M Bates, MD MSc, Parveen Wasi, MD FRCP(C), Nancy Robitaille, MD

Blood (2014) 124 (21): 2168.

https://doi.org/10.1182/blood.V124.21.2168.2168

Published: 2014

Journal Articles

A North American Experience Of Hemoglobin SC Disease, Its Complications, and Management

Veronique Naessens, MDCM, FRCPC, Richard Ward, MBBS, MSc, MRCP, FRCPath, Kevin H.M. Kuo, MD, FRCPC

Blood (2013) 122 (21): 2221.

https://doi.org/10.1182/blood.V122.21.2221.2221

Published: 2013

Journal Articles

Effectiveness Of An Analgesia Protocol For The Treatment Of Painful Vaso-Occlusive Crisis Of Sickle Cell Disease Patients In Emergency Room: A Retrospective Cohort Study

Veronique Naessens, MDCM, FRCPC, Richard Ward, MBBS, MSc, MRCP, FRCPath, Kevin H.M. Kuo, MD, FRCPC

Blood (2013) 122 (21): 2222.

https://doi.org/10.1182/blood.V122.21.2222.2222

Published: 2013

Journal Articles

Treatment Patterns and Outcomes Of Sickle Cell Patients With Frequent ER Visits: A Single Center Experience

Veronique Naessens, MDCM, FRCPC, Richard Ward, MBBS, MSc, MRCP, FRCPath, Kevin H.M. Kuo, MD, FRCPC

Blood (2013) 122 (21): 1010.

https://doi.org/10.1182/blood.V122.21.1010.1010

Published: 2013

Journal Articles

Characterization Of Pulmonary Compliance In Sickle Cell Patients Revealed Wide Variability

Hira S. Mian, MD, Kevin H.M. Kuo, MD, FRCPC, Vicki N. Wang, BA, Richard Ward, MBBS, MSc, MRCP, FRCPath, Susanna Mak, MD, FRCPC, PhD

Blood (2013) 122 (21): 989.

https://doi.org/10.1182/blood.V122.21.989.989

Published: 2013

Journal Articles

A Comparison of Chronic Manual and Automated Red Blood Cell Exchange Transfusion in Sickle Cell Disease Patients From Two Comprehensive Care Centres in the United Kingdom

Kevin H.M. Kuo, MD, FRCPC, Richard Ward, MBBS, MRCP, FRCPath, Jo Howard, MB, BChir, MRCP, FRCPath, Paul Telfer, MA, DM, BM, BCh, FRCP, FRCPath

Blood (2012) 120 (21): 3430.

https://doi.org/10.1182/blood.V120.21.3430.3430

Published: 2012

Journal Articles

A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease

Abdullah Kutlar, MD, Marvin Reid, PhD, Ali T Taher, MD, Adlette Inati, MD, Miguel R. Abboud, MD, Amal El-Beshlawy, MD, George R. Buchanan, MD, Hedy Smith, MD PhD, Kenneth I. Ataga, MD, Nebu Koshy, MD, FACP, Lynne D Neumayr, MD, Punam Malik, M.D., Ofelia A. Alvarez, MD, Richard Ward, MBBS, MRCP, FRCPath, J Michael White, PhD, Elsa Johnson, MBA, Richard G. Ghalie, MD

Blood (2012) 120 (21): 998.

https://doi.org/10.1182/blood.V120.21.998.998

Published: 2012

NARROW

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease Patients

Real World Experience with Sublingual Fentanyl for the Treatment of Sickle Cell Vaso-Occlusive Episodes in Adults in a Tertiary Canadian Emergency Department

Should Women with Sickle Cell Disease be Administered Prophylactic Transfusions to Avoid Complications during Pregnancy?

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Hemoglobinopathy Education in Canadian Hematology Training Programs: How Much Are Residents Learning?

A North American Experience Of Hemoglobin SC Disease, Its Complications, and Management

Effectiveness Of An Analgesia Protocol For The Treatment Of Painful Vaso-Occlusive Crisis Of Sickle Cell Disease Patients In Emergency Room: A Retrospective Cohort Study

Treatment Patterns and Outcomes Of Sickle Cell Patients With Frequent ER Visits: A Single Center Experience

Characterization Of Pulmonary Compliance In Sickle Cell Patients Revealed Wide Variability

A Comparison of Chronic Manual and Automated Red Blood Cell Exchange Transfusion in Sickle Cell Disease Patients From Two Comprehensive Care Centres in the United Kingdom

A Randomized, Open-Label, Multicenter, Dose Escalation Study of HQK-1001 (2,2-Dimethylbutyrate, Sodium Salt) in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only